Drug Profile
Melanoma vaccine - AVAX Technologies
Alternative Names: DNP-VACC; M-Vax; Melanoma vaccine DNP VACC; MVaxLatest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator AVAX Technologies
- Class Cancer vaccines; Conjugate vaccines; Dinitrobenzenes; Haptens
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Malignant melanoma